A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the brain. Researchers at Case Western Reserve University found that people ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Imagine losing your memories, your ability to recognize loved ones, or even perform daily tasks that once felt second nature. This is the painful reality for over 7 million Americans living with ...

A once-a-day pill that could completely revolutionise the treatment of Alzheimer’s disease has reached a significant ...